Package Insert: Information for the User
Dolintol 40 mg Hard Gastric-Resistant Capsules
Omeprazole
Read this package insert carefully before starting to take the medication.
Dolintol contains the active ingredient omeprazole. It belongs to a group of medicines called "proton pump inhibitors". These medicines work by reducing the amount of acid produced by the stomach.
Dolintol is used to treat the following diseases:
In adults:
In children:
Children over 1 year of age and = 10 kg
In children, symptoms of the disease may include the return of stomach contents to the mouth (regurgitation), vomiting, and insufficient weight gain.
Children over 4 years of age and adolescents
Do not take Dolintol if you are in any of the above situations. If you are unsure, talk to your doctor or pharmacist before taking Dolintol.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Dolintol.
Severe skin reactions have been reported in relation to omeprazole treatment, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized pustular psoriasis (AGPP). Stop taking Dolintol and consult your doctor immediately if you experience any of these symptoms related to severe skin reactions described in section 4.
Dolintol may mask the symptoms of other diseases. Therefore, if you experience any of the following symptoms before starting to take Dolintol or during treatment, consult your doctor immediately:
If you take Dolintol for a long period (more than 1 year), your doctor will probably perform regular check-ups. You should inform your doctor of any new or unusual symptoms and circumstances whenever you visit your doctor.
Taking a proton pump inhibitor like Dolintol, especially for more than a year, may slightly increase the risk of breaking a hip, wrist, or spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with Dolintol. Remember to mention any other symptoms you may notice, such as joint pain.
Omeprazole may cause kidney inflammation. Signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these signs.
This medicine may affect the way your body absorbs vitamin B12, especially if you need to take it for a long time. Contact your doctor if you notice any of the following symptoms, which may indicate low vitamin B12 levels:
Children
Some children with chronic diseases may require long-term treatment, although it is not recommended. Do not administer this medicine to children under 1 year of age or <10>
Other medicines and Dolintol
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine. This includes medicines that can be purchased without a prescription. This is because Dolintol may affect the mechanism of action of some medicines and some medicines may affect Dolintol.
Do not take Dolintol if you are taking a medicine that contains nelfinavir (used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medicines:
If your doctor has prescribed you amoxicillin and clarithromycin antibiotics to treat ulcers caused by Helicobacter pylori infection, it is very important to inform your doctor of any other medicines you are taking.
Taking Dolintol with food and drinks
See section 3.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant. Consult your doctor or pharmacist before using this medicine.
Omeprazole passes into breast milk but is unlikely to affect the baby when used in therapeutic doses.
Your doctor will decide if you can take Dolintol if you are breastfeeding.
Driving and operating machines
Dolintol is unlikely to affect your ability to drive or use tools or machines.
Adverse effects such as dizziness and visual disturbances (see section 4) may occur. If they do, patients should not drive or use machines.
Important information about some of the components of Dolintol
This medicine contains lactose and sucrose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medicine.
This medicine contains less than 23 mg of sodium (1mmol) per capsule; it is essentially "sodium-free".
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age. The usual doses are indicated below.
Adults:
Treatment of symptoms of ERGE, such asheartburn and acid regurgitation:
Treatment ofulcers in the upper part of the intestine(duodenal ulcer):
Treatment ofstomach ulcers(gastric ulcer):
Preventionof the reappearance ofstomach and duodenal ulcers:
Treatment of stomach and duodenal ulcers caused byNSAIDs:
Prevention of stomach and duodenal ulcersduring the administration ofNSAIDs:
Treatment ofulcers causedby the infectionbyHelicobacter pyloriand prevention of their reappearance:
Treatment of excess acid in the stomach caused by atumor in the pancreas (Zollinger-Ellison syndrome):
Use in children and adolescents:
Treatment of symptoms of ERGE, such asheartburn and acid regurgitation
Treatment ofulcers causedby the infectionHelicobacter pyloriand prevention of their reappearance:
How to take this medication
What to do if you or your child have trouble swallowing the capsules • If you or your child have trouble swallowing the capsules:
If you take more Dolintol than you should
If you have taken more Dolintol than prescribed by your doctor, consult your doctor or pharmacist immediately. You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Dolintol
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Dolintol
Do not interrupt the treatment with Dolintol without first speaking with your doctor or pharmacist.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
If you experience any of the following rare (may affect up to 1 in 1,000 people) or very rare (may affect up to 1 in 10,000 people) but serious side effects, stop taking Dolintol and consult your doctor immediately:
This could be "Stevens-Johnson syndrome" or "toxic epidermal necrolysis."
Other side effects are:
Frequent side effects (may affect up to 1 in 10 people)
• Headache.
Infrequent side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Unknown frequency (cannot be estimated from available data)
In very rare cases, omeprazole may affect white blood cells in the blood and cause immunodeficiency. If you experience an infection with symptoms such as fever with a very deteriorated general condition or fever with local infection symptoms, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medication.
Composition of Dolintol
The gelatin capsule is composed of: gelatin, indigotin (E-132) and erythrosine (E-127).
Appearance of the product and contents of the package
Dolintol 40 mg is presented in the form of hard gelatin capsules with a purple body and cap containing pellets with enteric coating.
Package sizes:
Packages containing 14, 28 or 56 capsules, and a clinical package with 500 capsules.
Only some package sizes may be commercially available.
Marketing Authorization Holder
ABABOR PHARMACEUTICALS, S.L.
C/Chile 4 – Edificio 1 – 28290 LAS ROZAS (Madrid)
Spain
Responsible for manufacturing:
INDUSTRIA QUÍMICA Y FARMACÉUTICA VIR, S.A.
C/Laguna 66-70. Polígono Industria URTINA II
28923 ALCORCÓN (Madrid)
Spain
Last review date of this leaflet: March 2025
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
The average price of Dolintol 40 mg capsulas duras gastrorresistentes in July, 2025 is around 2.5 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.